Evidence map›Paper›PMID 32894166›Full record

ArticleParasites & vectors2020

Sequence diversity of cytotoxic T cell antigens and satellite marker analysis of Theileria parva informs the immunization against East Coast fever in Rwanda.

David Kalenzi Atuhaire, Walter Muleya, Victor Mbao, Thomas Bazarusanga, Isidore Gafarasi, Jeremy Salt, Boniface Namangala, Antony Jim Musoke

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Antigenic and genotypic relatedness of buffalo-derivedInternational journal for parasitology. Parasites and wildlife · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Antigenic Diversity inFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

David Kalenzi AtuhaireCentre for Ticks and Tick-Borne Diseases, Private Bag A130, Lilongwe, Malawi.
Walter MuleyaDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, P.O. Box 32379, Lusaka, 10101, Zambia. muleyawalter@gmail.com.ORCID http://orcid.org/0000-0001-8874-3965
Victor MbaoInternational Development Research Centre, Eastern and Southern Africa Regional Office, Nairobi, Kenya.
Thomas BazarusangaAcre Africa, P.O. Box 6782, Kigali, Rwanda.
Isidore GafarasiRwanda Agricultural Board, P.O. Box 5016, Kigali, Rwanda.
Jeremy SaltGlobal Alliance for Livestock Veterinary Medicines, Doherty Building, Pentlands Science Park, Bush Loan, Penicuik, Edinburgh, EH26 0PZ, Scotland, UK.
Boniface NamangalaDepartment of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, P.O. Box 32379, Lusaka, 10101, Zambia.
Antony Jim MusokeLMK Medical laboratories and consultancies, P.O. Box 33686, Kampala, Uganda.
University of Zambia · ZMCentre of Ticks and Tick-borne diseases · MWGlobal Alliance for Livestock Veterinary Medicines · GBRwanda Agriculture Board · RW

Funding

Global Alliance for Livestock and Veterinary medicines (GALVmed) (UOZ-R34A0548A3)
6 · The paper itself

Abstract

backgroundEast Coast fever (ECF) caused by Theileria parva is endemic in Rwanda. In this study, the antigenic and genetic diversity of T. parva coupled with immunization and field challenge were undertaken to provide evidence for the introduction of ECF immunization in Rwanda.

methodsBlood collected from cattle in the field was screened for T. parva using ELISA and PCR targeting the p104 gene. Tp1 and Tp2 gene sequences were generated from field samples and from Gikongoro and Nyakizu isolates. Furthermore, multilocus genotype data was generated using 5 satellite markers and an immunization challenge trial under field conditions using Muguga cocktail vaccine undertaken.

resultsOut of 120 samples, 44 and 20 were positive on ELISA and PCR, respectively. Antigenic diversity of the Tp1 and Tp2 gene sequences revealed an abundance of Muguga, Kiambu and Serengeti epitopes in the samples. A further three clusters were observed on both Tp1 and Tp2 phylogenetic trees; two clusters comprising of field samples and vaccine isolates and the third cluster comprising exclusively of Rwanda samples. Both antigens exhibited purifying selection with no positive selection sites. In addition, satellite marker analysis revealed that field samples possessed both shared alleles with Muguga cocktail on all loci and also a higher proportion of unique alleles. The Muguga cocktail (Muguga, Kiambu and Serengeti) genotype compared to other vaccine isolates, was the most represented in the field samples. Further low genetic sub-structuring (F

conclusionsAntigenic and genetic diversity analysis of T. parva facilitated the use of Muguga cocktail vaccine in field conditions. A protection level of 81.7% was achieved, demonstrating the importance of combining molecular tools with field trials to establish the suitability of implementation of immunization campaigns. Based on the information in this study, Muguga cocktail immunization in Rwanda has a potential to produce desirable results.

Indexed as

Theileria parvaTheileriasisAnimalsAntigenic VariationAntigens, ProtozoanCattleCattle DiseasesDNA, SatelliteEnzyme-Linked Immunosorbent AssayGenes, ProtozoanGenetic MarkersGenetic VariationImmunizationPhylogenyPolymerase Chain ReactionPolymorphism, GeneticAntigens, ProtozoanDNA, SatelliteGenetic MarkersProtozoan VaccinesECFImmunizationMuguga cocktailSub-structuringTheileria parvaTp1Tp2

Identifiers

PMID32894166
PMCPMC7487574
OpenAlexW3083518182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.